Mage Biologics announces first subject dosed in a Phase 1 trial with MB-001, an orally administered antibody for Inflammatory Bowel Disease
June 12, 2024
June 12, 2024
June 11, 2024
June 6, 2024
June 5, 2024
May 29, 2024
May 29, 2024
May 22, 2024
May 15, 2024
May 15, 2024
January 9, 2026
Cycle Pharmaceuticals Ltd (Cycle) and Inceptua Group (Inceptua) have announced the expansion of their partnership to make NITYR® (nitisinone) tablets ...
December 4, 2025
The study reinforces that ME is a complex multisystemic condition with a clear genetic basis and lays the foundation for future clinical trials that c...
October 30, 2025
Lonza to acquire Redberry SAS, an innovative company specializing in rapid microbiology testing solutions Acquisition to include Red One™ solid-phase ...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225